Impact of PD-L1 Expression and Tumor Microenvironments on Osimertinib Efficacy in Pretreated Non-Small-Cell Lung Cancer Harboring an Acquired EGFRT790M Mutation
Year: 2022
Type: preprint
Study design: Observational Study
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4204347
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4296833514
